SIGALA, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 13.330
AS - Asia 5.889
EU - Europa 5.229
SA - Sud America 990
Continente sconosciuto - Info sul continente non disponibili 350
AF - Africa 133
OC - Oceania 20
Totale 25.941
Nazione #
US - Stati Uniti d'America 12.980
SG - Singapore 2.000
CN - Cina 1.929
IT - Italia 1.014
UA - Ucraina 899
BR - Brasile 790
HK - Hong Kong 650
DE - Germania 627
PL - Polonia 585
FR - Francia 481
FI - Finlandia 462
VN - Vietnam 408
GB - Regno Unito 313
RU - Federazione Russa 226
IN - India 191
TR - Turchia 188
CA - Canada 185
BD - Bangladesh 178
IE - Irlanda 162
SE - Svezia 96
LT - Lituania 73
NL - Olanda 62
JP - Giappone 60
AR - Argentina 59
BE - Belgio 58
ID - Indonesia 50
IQ - Iraq 43
ZA - Sudafrica 40
MX - Messico 39
EC - Ecuador 37
CZ - Repubblica Ceca 34
ES - Italia 32
PK - Pakistan 28
VE - Venezuela 26
IL - Israele 25
CO - Colombia 24
CR - Costa Rica 23
CL - Cile 22
AT - Austria 18
AU - Australia 17
JM - Giamaica 17
MA - Marocco 16
NG - Nigeria 16
EE - Estonia 15
HN - Honduras 14
SA - Arabia Saudita 14
DK - Danimarca 13
GT - Guatemala 13
TT - Trinidad e Tobago 13
UZ - Uzbekistan 13
CH - Svizzera 11
EG - Egitto 11
IR - Iran 11
KE - Kenya 11
PY - Paraguay 11
NI - Nicaragua 9
PH - Filippine 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 7
DZ - Algeria 7
LB - Libano 7
NP - Nepal 7
PE - Perù 7
PS - Palestinian Territory 7
SC - Seychelles 7
AZ - Azerbaigian 6
JO - Giordania 6
KR - Corea 6
MU - Mauritius 6
SV - El Salvador 6
UY - Uruguay 6
BO - Bolivia 5
CW - ???statistics.table.value.countryCode.CW??? 5
DO - Repubblica Dominicana 5
GR - Grecia 5
KZ - Kazakistan 5
MY - Malesia 5
OM - Oman 5
PT - Portogallo 5
TH - Thailandia 5
TW - Taiwan 5
AL - Albania 4
BH - Bahrain 4
EU - Europa 4
GD - Grenada 4
HU - Ungheria 4
KG - Kirghizistan 4
PR - Porto Rico 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BS - Bahamas 3
GE - Georgia 3
GP - Guadalupe 3
GY - Guiana 3
LV - Lettonia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
Totale 25.565
Città #
Ashburn 1.275
Fairfield 1.046
Singapore 1.009
Woodbridge 835
San Jose 719
Jacksonville 654
Hong Kong 644
Warsaw 578
Houston 534
Council Bluffs 486
Seattle 428
Cambridge 421
Dallas 404
Ann Arbor 377
Beijing 367
Wilmington 356
Chandler 331
Los Angeles 299
The Dalles 293
Princeton 289
Helsinki 276
Chicago 265
New York 264
Nanjing 227
Brescia 224
Dearborn 169
Dublin 161
Lauterbourg 156
Istanbul 150
Columbus 144
Ho Chi Minh City 124
Des Moines 109
Nanchang 108
Munich 106
Buffalo 104
Santa Clara 104
Salt Lake City 102
Milan 86
Moscow 86
São Paulo 79
Hanoi 76
Shenyang 70
Secaucus 68
Shanghai 66
Turku 64
Toronto 63
San Francisco 62
Vilnius 62
Changsha 60
San Diego 58
Jinan 57
Brussels 56
Redondo Beach 55
Elk Grove Village 54
Orem 54
Tianjin 54
Tampa 53
Dong Ket 48
Hebei 48
Rome 48
Phoenix 47
North Bergen 46
Pune 45
Lancaster 43
London 42
West Jordan 42
Boardman 41
Tokyo 38
Brooklyn 35
Kunming 32
Jakarta 31
Jiaxing 31
Montreal 31
Sterling 31
Ningbo 28
Atlanta 26
Chennai 25
Frankfurt am Main 25
Rio de Janeiro 25
Verona 24
Boston 23
Brno 23
Zhengzhou 23
Hangzhou 22
Johannesburg 22
Miami 22
Nuremberg 22
Stockholm 22
Amsterdam 21
Denver 21
Guangzhou 21
Naples 21
Taizhou 21
Haiphong 20
San José 19
Dalmine 18
Turin 18
Brasília 17
Haikou 17
Poplar 17
Totale 16.663
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 808
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 400
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 390
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 339
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 304
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 294
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 292
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 275
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 265
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 264
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 240
Immunotherapy failure in adrenocortical cancer: where next? 231
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 224
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 221
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 221
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 221
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 221
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 220
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 220
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 219
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 218
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 214
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 212
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 211
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 209
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 208
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 206
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 203
A new pharmacological approach to the facilitation of acetylcholine transmission. 201
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 201
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 197
Palbociclib inhibits proliferation of human adrenocortical tumor cells 196
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 196
Should we be cautious on the use of commercially available antibodies to dopamine receptors? 194
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 192
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 192
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 191
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 186
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 186
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 185
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 181
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 180
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 176
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 176
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 174
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 173
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 170
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 170
INVOLVEMENT OF TARGET GENE POLYMORPHISMS IN 5-FLUOROURACIL TOXICITY: A CASE REPORT 167
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 164
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? 163
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 162
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines 159
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 159
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 159
Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer 155
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. 154
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 153
Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. 153
Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs 153
Adrenocortical carcinoma 151
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 146
Different neurotransmitter systems are involved in the development of esophageal achalasia 144
Sex-related variations in serum nerve growth factor concentration in humans. 143
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 142
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 141
Detection of muscarinic receptor subtypes in human urinary bladder mucosa: Age and gender-dependent modifications 141
I RECETTORI ADRENERGICI ALFA-1 NELL'APPARATO URINARIO UMANO: ESPRESSIONE DISTRIBUZIONE E LORO IMPLICAZIONI CLINICHE 141
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 141
Nerve growth factor signaling in prostate health and disease. 140
Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. 139
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 139
Clinical Outcome After Extended Endovascular Recanalization in Buerger's Disease in 20 Consecutive Cases. 138
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 137
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 137
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 137
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 137
Erratum to "Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa" [Pharmacol. Res. 64 (2011) 420-425] 137
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure 136
Dopamine receptors are present in rat and human esophagus 136
Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment 136
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 135
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 135
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 132
Caffeine inhibits Direct and Indirect Angiogenesis in zebrafish embryos 131
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 130
Ruolo dei recettori della dopamina nella regolazione motoria dello sfintere esofageo inferiore del ratto 130
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 130
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice. 129
Evidence for the presence of D1 and D2 dopamine receptors in rat oesophagus 128
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism 128
Stimulation of muscarinic receptors induces cell proliferation of human detrusor muscle cell 128
FSCN1 as a new druggable target in adrenocortical carcinoma 128
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines 127
ALPHA 1 ADRENERGIC RECEPTOR SUBTYPES IN MALE AND FEMALE HUMAN URINARY BLADDER: SEX AND REGIONAL COMPARISON 127
Structural comparison Analysis of Erythropoietin and its biosimilars by a proteomic approach 127
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 127
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 126
Ruolo della dopamina e del VIP nella patogenesi dell'acalasia esofagea 125
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 124
Totale 18.554
Categoria #
all - tutte 114.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022844 0 0 0 0 15 58 63 76 61 152 111 308
2022/20231.060 188 62 47 79 81 258 6 87 131 14 39 68
2023/20241.391 70 39 125 99 81 250 49 66 282 70 34 226
2024/20254.142 55 46 32 522 341 246 294 109 491 248 942 816
2025/20266.949 550 864 757 917 608 391 978 312 436 668 292 176
2026/20272.397 332 291 576 1.077 121 0 0 0 0 0 0 0
Totale 25.941